View Older Stories View More Recent Stories

Mar 4, 2021 09:05AM Lumos Pharma (LUMO) Says Data Supporting Use of Predictive Enrichment Markers for its LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 3, 2021 09:00AM Empire BlueCross BlueShield Partners with On-Demand Healthcare Service Ready to Provide New York City Residents Medical Care in Their Homes
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 1, 2021 07:00AM FogPharma® Announces $107 Million Series C Financing to Advance Direct β-Catenin Antagonist and Universal Druggability™ Platform
Feb 25, 2021 07:00AM Jaguar Gene Therapy Launches with Mission to Accelerate Breakthroughs in Gene Therapy for Patients Suffering from Severe Genetic Diseases
Feb 25, 2021 07:00AM Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
Feb 25, 2021 07:00AM Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
Feb 25, 2021 01:00AM Valneva Reports FY 2020 Results and Major Corporate Achievements
Feb 25, 2021 01:00AM Valneva Reports FY 2020 Results and Major Corporate Achievements
Feb 24, 2021 09:00AM Independence Blue Cross and Quartet Health Collaborate to Address Behavioral Health
Feb 24, 2021 06:00AM Xilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective Immuno-Oncology Pipeline
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 16, 2021 04:38PM Form 13F-HR DEERFIELD MANAGEMENT For: Dec 31
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 10, 2021 04:05PM Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
Feb 10, 2021 09:05AM ConcertoHealth and Perfect Health Are Now ConcertoCare
Feb 10, 2021 07:02AM Sema4 to Combine with SPAC, CM Life Sciences (CMLF)
Feb 10, 2021 07:00AM  Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth
Feb 8, 2021 08:00AM Dana-Farber Cancer Institute and Deerfield Management Launch Riverway Discoveries
Feb 3, 2021 09:35AM Pairwise Raises $90 Million to Bring New Varieties of Fruits and Vegetables to Market
Feb 3, 2021 08:00AM SpectraWAVE Announces $13.2 Million Series A-2 Financing from Existing Investors to Bring Intracoronary Imaging Technology to Market
Jan 27, 2021 08:00AM Encodia Closes $75M Series C Financing Led by Northpond Ventures and Deerfield Management
Jan 27, 2021 06:00AM Nuvalent Launches with $50M Series A Financing from Deerfield Management to Develop Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Jan 22, 2021 09:03AM COVID Test Results in 15min with New At-Home Test Service from Ready
Jan 21, 2021 12:00AM MIVI Neuroscience Secures Series B Funding
Jan 19, 2021 07:00AM Terns Announces FDA Clearance of Investigational New Drug (IND) Application for First-in-Human Phase 1 Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH
Jan 15, 2021 11:45AM Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms
Jan 15, 2021 11:45AM Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms
Jan 12, 2021 07:00AM Terns Completes Enrollment in Phase 2a Clinical Trial of TERN-101 in NASH Patients
Jan 11, 2021 08:30AM Avidity Biosciences Announces Changes to its Board of Directors
Jan 11, 2021 07:00AM Blade Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 7, 2021 11:45AM Valneva Reports FY 2020 Cash of Over €200 Million
Jan 7, 2021 11:45AM Valneva Reports FY 2020 Cash of Over €200 Million
Jan 7, 2021 07:00AM Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Jan 5, 2021 04:35PM Terns Appoints Three New Independent Directors to its Board
Jan 5, 2021 07:00AM Terns Closes $87 Million Series C Financing to Advance NASH Portfolio
Dec 30, 2020 04:23PM Form 13F-HR/A DEERFIELD MANAGEMENT For: Sep 30
Dec 22, 2020 08:00AM Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
Dec 22, 2020 08:00AM  Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders
Dec 22, 2020 08:00AM  Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders
Dec 21, 2020 05:20PM Form SC 13D/A Deerfield Healthcare Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Dec 18, 2020 11:35AM Deerfield Healthcare Technology Acquisitions (DFHT) Announces Proposed Business Combination to Form CareMax
Dec 18, 2020 11:30AM Deerfield Healthcare Technology Acquisitions Corp. Announces Proposed Business Combination to Form CareMax
Dec 18, 2020 09:00AM Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
Dec 18, 2020 09:00AM Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
View More Recent Stories View Older Stories